Eric Hyllengren | Vice President of Investor Relations & Finance |
Pascal Touchon | President & Chief Executive Officer |
Jakob Dupont | Executive Vice President & Global Head of Research & Development |
Utpal Koppikar | Chief Financial Officer |
Joe Newell | Chief Operations Officer |
AJ Joshi | Chief Medical Officer |
Kristin Yarema | Chief Commercial Officer |
John Newman | Canaccord |
Salim Syed | Mizuho |
Jonathan Miller | Evercore ISI |
Ben Burnett | Stifel |
Marc Frahm | Cowen |
Samantha Semenkow | Citi |
Matt Phipps | William Blair |
Tessa Romero | JPMorgan |
Maury Raycroft | Jefferies |
Salveen Richter | Goldman Sachs |
Tony Butler | ROTH Capital |
Michael DiFiore | Evercore ISI |
Ladies and gentlemen, thank you for standing by and welcome to the Atara Biotherapeutics Q3 2020 Financial Results Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to your speaker today, Eric Hyllengren, VP of Investor Relations and Finance at Atara Biotherapeutics. Thank you.